Histone deacetylase inhibitors as differentiation agents in breast cancer cells

被引：0
|
作者：
Ismail, H. [1 ]
Bail, M. [1 ]
Laperriere, D. [1 ]
Mader, S. [1 ,2 ]
机构：
[1] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada
[2] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada
来源：
FEBS JOURNAL | 2014年 / 281卷
关键词：
breast cancer; Differentiation; Histone deacetylase inhibitors;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
MON-158
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [31] Histone deacetylase inhibitors enhance osteoblast differentiation
    Westendorf, JJ
    Schroeder, TM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P59 - P59
  • [32] Regulation of adipocyte differentiation by histone deacetylase inhibitors
    Kim, Su-Nam
    Choi, Hye-Young
    Kim, Yong Kee
    ARCHIVES OF PHARMACAL RESEARCH, 2009, 32 (04) : 535 - 541
  • [33] Histone deacetylase inhibitors: Multifunctional anticancer agents
    Liu, Tao
    Kuljaca, Selena
    Tee, Andrew
    Marshall, Glenn M.
    CANCER TREATMENT REVIEWS, 2006, 32 (03) : 157 - 165
  • [34] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells
    Munster, PN
    Troso-Sandoval, T
    Rosen, N
    Rifkind, R
    Marks, PA
    Richon, VM
    CANCER RESEARCH, 2001, 61 (23) : 8492 - 8497
  • [35] Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells
    Cody, James J.
    Markert, James M.
    Hurst, Douglas R.
    PLOS ONE, 2014, 9 (03):
  • [36] Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells
    Gonçalves, J
    Malta-Vacas, J
    Louis, M
    Brault, L
    Bagrel, D
    Monteiro, C
    Brito, M
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (02) : 151 - 156
  • [37] Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs
    Shi, Yehui
    Jia, Yongsheng
    Zhao, Weipeng
    Zhou, Liyan
    Xie, Xiaojuan
    Tong, Zhongsheng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (01) : 435 - 442
  • [38] Histone deacetylase inhibitors abrogate the levels and activity of estrogen receptor (ER) α and histone deacetylase (HDAC) 6 in human breast cancer cells (BCCs)
    Fiskus, W.
    Mohapatra, A.
    Bali, P.
    Balasis, M.
    Rao, R.
    Atadja, P.
    Wu, J.
    Bhalla, K.
    EJC SUPPLEMENTS, 2006, 4 (12): : 177 - 177
  • [39] Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
    Alzoubi, Samer
    Brody, Leigh
    Rahman, Sunniyat
    Mahul-Mellier, Anne-Laure
    Mercado, Nicolas
    Ito, Kazuhiro
    El-Bahrawy, Mona
    Silver, Andrew
    Boobis, Alan
    Bell, Jimmy D.
    Hajji, Nabil
    ONCOTARGET, 2016, 7 (28) : 44505 - 44521
  • [40] Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
    Damaskos, Christos
    Valsami, Serena
    Kontos, Michael
    Spartalis, Eleftherios
    Kalampokas, Theodoros
    Kalampokas, Emmanouil
    Athanasiou, Antonios
    Moris, Demetrios
    Daskalopoulou, Afrodite
    Davakis, Spyridon
    Tsourouflis, Gerasimos
    Kontzoglou, Konstantinos
    Perrea, Despina
    Nikiteas, Nikolaos
    Dimitroulis, Dimitrios
    ANTICANCER RESEARCH, 2017, 37 (01) : 35 - 46
12345